NDC 64406-019 – Byooviz
Ranibizumab 10 mg/mL · Injection, Solution · Intravitreal
Product NDC64406-019
Product details
- Brand name
- Byooviz
- Generic name
- Ranibizumab-nuna
- Labeler
- BIOGEN INC.
- Dosage form
- Injection, Solution
- Route
- Intravitreal
- Marketing category
- BLA · BLA761202
- Marketed since
- June 1, 2022
- Marketing end
- July 19, 2028
- Pharmacologic class
- Vascular Endothelial Growth Factor Inhibitor
Active ingredients
- Ranibizumab 10 mg/mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 64406-019-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (64406-019-01) / .05 mL in 1 VIAL, SINGLE-DOSE (64406-019-07) | Jun 1, 2022 |
| 64406-019-08 | 1 VIAL, SINGLE-DOSE in 1 CARTON (64406-019-08) / .05 mL in 1 VIAL, SINGLE-DOSE (64406-019-09) | Oct 3, 2022 |
Other Byooviz products
- 82667-018 Ranibizumab 10 mg/mL · Injection, Solution · Harrow Eye, LLC